Correlation Engine 2.0
Clear Search sequence regions

Azepino[4,5-b]indoles have been identified as potent agonists of the farnesoid X receptor (FXR). In vitro and in vivo optimization has led to the discovery of 6m (XL335, WAY-362450) as a potent, selective, and orally bioavailable FXR agonist (EC(50) = 4 nM, Eff = 149%). Oral administration of 6m to LDLR(-/-) mice results in lowering of cholesterol and triglycerides. Chronic administration in an atherosclerosis model results in significant reduction in aortic arch lesions.


Brenton Flatt, Richard Martin, Tie-Lin Wang, Paige Mahaney, Brett Murphy, Xiao-Hui Gu, Paul Foster, Jiali Li, Parinaz Pircher, Mary Petrowski, Ira Schulman, Stefan Westin, Jay Wrobel, Grace Yan, Eric Bischoff, Chris Daige, Raju Mohan. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). Journal of medicinal chemistry. 2009 Feb 26;52(4):904-7

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 19159286

View Full Text